Medication Optimization for Inadequate ADHD Response

Rationale for Dose Optimization

• The American Academy of Child and Adolescent Psychiatry recommends increasing the total daily amphetamine dose to the maximum recommended range of 40 mg/day for patients with inadequate ADHD response 1
• Clinical practice parameters emphasize that if the top recommended dose does not help, more is not necessarily better, but this patient has not yet reached the top recommended dose 1

Specific Titration Protocol

• The American Academy of Child and Adolescent Psychiatry suggests increasing the Adderall IR component by 5 mg increments weekly until reaching 40 mg total daily amphetamine or achieving symptom control 1, 2
• Standardized ADHD rating scales should be obtained from the patient before each dose increase to objectively measure improvement in executive function and task initiation 2

Monitoring Requirements During Titration

• The American Academy of Child and Adolescent Psychiatry recommends systematic assessment at each weekly contact, including target symptoms, vital signs, side effects, and weight 1, 2, 3, 4
• Blood pressure and pulse should be monitored at each in-person visit 3, 4
• Side effects such as decreased appetite, insomnia, headaches, irritability, and social withdrawal should be systematically queried 1, 2

Alternative Strategies If Maximum Dose Fails

• If 40 mg/day amphetamine does not adequately control executive dysfunction and task initiation, the American Academy of Child and Adolescent Psychiatry recommends switching to a different stimulant class, such as methylphenidate 1, 4
• Methylphenidate has a different mechanism of action and may be effective when amphetamines fail 4, 5

Adjunctive Non-Stimulant Consideration

• The American Academy of Child and Adolescent Psychiatry suggests adding atomoxetine or guanfacine as adjunctive therapy if stimulant optimization alone proves insufficient for executive function deficits 3, 4
• Atomoxetine provides "around-the-clock" norepinephrine reuptake inhibition that may complement stimulant effects on executive function 3, 4
• Guanfacine enhances prefrontal cortex function through alpha-2A adrenergic agonism and may specifically improve working memory and impulse control 3, 4

Critical Pitfalls to Avoid

• The American Academy of Child and Adolescent Psychiatry recommends not prematurely switching medication classes, as the patient has not yet reached the maximum recommended amphetamine dose 1, 2
• Non-stimulants should not be added before maximizing stimulant dose, as guidelines emphasize that stimulants have the largest effect sizes for ADHD core symptoms 3, 4

Timeline for Reassessment

• A follow-up visit should be scheduled at 4 weeks to comprehensively evaluate response using standardized measures 1, 2
• If executive function and task initiation improve substantially, the current regimen should be continued with monthly monitoring 2
• If partial response, consider adjunctive non-stimulant as described above 3, 4
• If no response at maximum dose, switch to methylphenidate class 1, 4

Initial ADHD Medication Dosing

Recommended Starting Doses

• The American Academy of Child and Adolescent Psychiatry recommends starting with methylphenidate 5 mg twice daily or amphetamine/dextroamphetamine 2.5 mg once daily in the morning, then titrate upward weekly based on symptom response and tolerability 6, 7

Methylphenidate (MPH) Initiation

• Start with 5 mg given twice daily, with an optional third dose after school if needed for homework and social activities, as recommended by the American Academy of Child and Adolescent Psychiatry 6, 7
• Increase by 5-10 mg increments weekly until symptoms improve or side effects emerge, according to the American Academy of Child and Adolescent Psychiatry 6, 7, 8

Amphetamine/Dextroamphetamine (AMP/DEX) Initiation

• Start with 2.5 mg once daily in the early morning for children, as recommended by the American Academy of Child and Adolescent Psychiatry 6, 7
• For adults, start with 10 mg once daily in the morning, as recommended by Praxis Medical Insights 8, 9

Titration Strategy: Fixed vs Flexible Dosing

• Increase dose weekly based on symptom improvement and side effect profile, as recommended by the American Academy of Child and Adolescent Psychiatry 6, 7
• Obtain standardized ADHD rating scales from teachers/parents for children, or from patient/significant other for adults before each increase, according to the American Academy of Child and Adolescent Psychiatry 6, 7

Pre-Treatment Assessment Requirements

• Before initiating stimulants, perform cardiovascular screening, family history, tic assessment, and substance use screening, as recommended by Praxis Medical Insights 8, 9

Monitoring During Titration

• Schedule follow-up appointments at least monthly until symptoms stabilize, as recommended by Praxis Medical Insights 8, 10, 9
• Assess both therapeutic response and adverse effects at each dose adjustment using standardized rating scales, according to Praxis Medical Insights 8, 10

Special Populations

• For older adults, more conservative titration is recommended, increasing by 5 mg every 2 weeks instead of weekly, as recommended by Praxis Medical Insights 9
• Older adults are more sensitive to both therapeutic and adverse effects due to age-related pharmacokinetic changes, according to Praxis Medical Insights 9

When to Consider Alternative Treatments

• If adequate symptom control is not achieved at maximum dose, or intolerable side effects occur, consider alternative treatments, such as switching to an alternative stimulant formulation or non-stimulant medications, as recommended by Praxis Medical Insights 8, 9